Morton Brown Family Wealth, LLC Ab Cellera Biologics Inc. Transaction History
Morton Brown Family Wealth, LLC
- $287 Million
- Q4 2024
A detailed history of Morton Brown Family Wealth, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Morton Brown Family Wealth, LLC holds 75 shares of ABCL stock, worth $232. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$232
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ABCL
# of Institutions
155Shares Held
108MCall Options Held
153KPut Options Held
194K-
Baker Bros. Advisors LP New York, NY27.5MShares$85.3 Million0.76% of portfolio
-
Baillie Gifford & CO12.2MShares$37.9 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$32.9 Million0.03% of portfolio
-
Prosight Management, LP Dallas, TX9.08MShares$28.1 Million6.31% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.59MShares$14.2 Million0.0% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $884M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...